207 related articles for article (PubMed ID: 34610896)
21. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
22. Invasive and Noninvasive Progression After Resection of Noninvasive Intraductal Papillary Mucinous Neoplasms.
Amini N; Habib JR; Blair A; Rezaee N; Kinny-Köster B; Cameron JL; Hruban RH; Weiss MJ; Fishman EK; Lafaro KJ; Zaheer A; Manos L; Burns WR; Burkhart R; He J; Yu J; Wolfgang CL
Ann Surg; 2022 Aug; 276(2):370-377. PubMed ID: 33201121
[TBL] [Abstract][Full Text] [Related]
23. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
[TBL] [Abstract][Full Text] [Related]
24. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
[TBL] [Abstract][Full Text] [Related]
25. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
26. Multifocal intraductal papillary mucinous neoplasm of the pancreas from mild dysplasia to invasive carcinoma A case report.
Mirarchi M; De Raffele E; Santini D; Calculli L; Cuicchi D; Lecce F; Cola B
Ann Ital Chir; 2016; 87():97-102. PubMed ID: 27026478
[TBL] [Abstract][Full Text] [Related]
27. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
28. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
[TBL] [Abstract][Full Text] [Related]
29. Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).
Sereni E; Luchini C; Salvia R; Pea A
Chin Clin Oncol; 2019 Apr; 8(2):21. PubMed ID: 31070041
[TBL] [Abstract][Full Text] [Related]
30. Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm.
Fujita Y; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Ueno M; Hayami S; Kobayashi R; Yanagisawa A; Yamaue H
Eur J Surg Oncol; 2022 May; 48(5):1054-1061. PubMed ID: 34933794
[TBL] [Abstract][Full Text] [Related]
31. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
32. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
33. [The Laparoscopic Enucleation for Branch Duct Type Intraductal Papillary Mucinous Neoplasms Located at the Body of Pancreas: A Case Report].
Stevanović D; Stojanović D; Mitrović N; Jašarović D; Milenković S; Bokun-Vukašinović Z; Radovanović D
Srp Arh Celok Lek; 2015; 143(5-6):332-6. PubMed ID: 26259409
[TBL] [Abstract][Full Text] [Related]
34. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.
Pulvirenti A; Margonis GA; Morales-Oyarvide V; McIntyre CA; Lawrence SA; Goldman DA; Gonen M; Weiss MJ; Ferrone CR; He J; Brennan MF; Cameron JL; Lillemoe KD; Kingham TP; Balachandran V; Qadan M; D'Angelica MI; Jarnagin WR; Wolfgang CL; Castillo CF; Allen PJ
Ann Surg; 2021 Dec; 274(6):e980-e987. PubMed ID: 31804389
[TBL] [Abstract][Full Text] [Related]
35. [Surgical management of intraductal papillary mucinous neoplasms].
Jang JY
Korean J Gastroenterol; 2008 Oct; 52(4):220-5. PubMed ID: 19077523
[TBL] [Abstract][Full Text] [Related]
36. Two cases of pancreatic colloid carcinoma with different pathogenesis: case report and review of the literature.
Yasuoka H; Kato H; Asano Y; Ito M; Arakawa S; Kawabe N; Shimura M; Koike D; Hayashi C; Ochi T; Kamio K; Kawai T; Higashiguchi T; Kiriyama Y; Urano M; Horiguchi A
Clin J Gastroenterol; 2022 Jun; 15(3):649-661. PubMed ID: 35048322
[TBL] [Abstract][Full Text] [Related]
37. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.
Ammori JB; Do RK; Brennan MF; D'Angelica MI; Dematteo RP; Fong Y; Jarnagin WR; Allen PJ
J Gastrointest Surg; 2014 May; 18(5):911-6. PubMed ID: 24448998
[TBL] [Abstract][Full Text] [Related]
38. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
[TBL] [Abstract][Full Text] [Related]
39. Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status: Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance.
Kim HS; Han Y; Kang JS; Choi YJ; Byun Y; Kim H; Lee KB; Kim H; Kwon W; Jang JY
Ann Surg; 2022 Oct; 276(4):e231-e238. PubMed ID: 32941274
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm.
Chapman BC; Paniccia A; Ryan C; Schulick RD; Edil BH
Ann Surg Oncol; 2017 Feb; 24(2):560. PubMed ID: 27590330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
